NYSE · SRXH
Healthcare · Drug Manufacturers - General
$1.83
Down-$0.01 (-0.54%)
Updated Aug 14, 2026, 9:05 AM
SID Score
6.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
SRXH closed at $1.83 after 21 trading sessions, down 24.07% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $1.82 | $1.845 | $1.67 | $1.83 | 1.65M |
| Aug 12, 2026 | $1.86 | $1.93 | $1.80 | $1.84 | 981.28K |
| Aug 11, 2026 | $1.75 | $1.89 | $1.6409 | $1.84 | 928.39K |
| Aug 10, 2026 | $1.56 | $1.79 | $1.56 | $1.73 | 1.64M |
| Aug 7, 2026 | $1.44 | $1.59 | $1.41 | $1.59 | 1.1M |
| Aug 6, 2026 | $1.42 | $1.485 | $1.37 | $1.43 | 954.6K |
| Aug 5, 2026 | $1.37 | $1.39 | $1.30 | $1.39 | 718.33K |
| Aug 4, 2026 | $1.45 | $1.50 | $1.33 | $1.37 | 1.36M |
| Aug 3, 2026 | $1.37 | $1.49 | $1.32 | $1.44 | 1.07M |
| Jul 31, 2026 | $1.51 | $1.51 | $1.37 | $1.38 | 1.06M |
| Jul 30, 2026 | $1.46 | $1.72 | $1.46 | $1.48 | 1.76M |
| Jul 29, 2026 | $1.46 | $1.59 | $1.425 | $1.45 | 990.78K |
| Jul 28, 2026 | $1.57 | $1.64 | $1.45 | $1.48 | 1.44M |
| Jul 27, 2026 | $1.77 | $1.89 | $1.59 | $1.59 | 1.23M |
| Jul 24, 2026 | $1.74 | $1.85 | $1.63 | $1.80 | 1.7M |
| Jul 23, 2026 | $1.92 | $1.98 | $1.80 | $1.80 | 1.38M |
| Jul 22, 2026 | $1.86 | $2.06 | $1.765 | $1.97 | 2.69M |
| Jul 21, 2026 | $2.10 | $2.16 | $1.91 | $2.02 | 3.44M |
| Jul 20, 2026 | $2.23 | $2.27 | $2.11 | $2.17 | 1.79M |
| Jul 17, 2026 | $2.35 | $2.5852 | $2.25 | $2.33 | 2.79M |
| Jul 16, 2026 | $2.25 | $2.49 | $2.01 | $2.41 | 8.9M |
The latest Smart Investors Daily articles mentioning SRXH.
SRXH research
Company profile and research snapshot.
SRX HealthSolutions Inc operates the continuing pet health and wellness business under the Halo brand, offering premium and super-premium foods, treats, toppers, chews, dental products and supplements for dogs and cats. The company provides high-quality pet products formulated to meet high-quality sourcing and nutritional standards and produced through co-manufacturing relationships. Its Consumer Products segment includes the legacy Halo pet food business with premium products such as dry kibble, wet food, freeze-dried raw food, treats and toppers. Products are sold across e-commerce platforms such as Amazon and Chewy, select retail partners, and international distributors, with operations mainly in the United States, Taiwan and other markets.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Aug 4, 2026
The Company views Vistagen shares as undervalued and welcomes constructive engagement with its leadership team and Board of Directors to discuss ideas on how to unlock shareholder value.
Benzinga · Jul 31, 2026
Jersey Mike's Subs began trading Friday on the NYSE after pricing its IPO at $23 per share, valuing the chain at $1 billion.
Benzinga · Jul 30, 2026
SRX Global Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic
Benzinga · Jul 14, 2026
SRX Global Inc. (NYSE American: SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today reported paper-traded
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SRXH.
